GMED

56.57

5.10% -3.04

Handel nachbörslich: 56.57

Globus Medical Inc (GMED)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$59.61

Offen:

$59.75

24-Stunden-Volumen:

1.04M

Relative Volume:

0.75

Marktkapitalisierung:

$7.64B

Einnahmen:

$2.51B

Nettoeinkommen (Verlust:

$185.56M

KGV:

42.22

EPS:

1.34

Netto-Cashflow:

$517.59M

1W Leistung:

-6.46%

1M Leistung:

-3.20%

6M Leistung:

-20.30%

1J Leistung:

-18.94%

1-Tages-Spanne:

$56.50

$59.90

1-Wochen-Bereich:

$56.50

$61.64

52-Wochen-Spanne:

$51.79

$94.93

Globus Medical Inc Stock (GMED) Company Profile

Firmenname

Globus Medical Inc

Sektor

Healthcare (1141)

Branche

Medical Devices (149)

Telefon

610-930-1800

Adresse

2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA

Mitarbeiter

5,300

Twitter

@GlobusMedical

Nächster Verdiensttermin

2024-11-05

Neueste SEC-Einreichungen

GMED's Discussions on Twitter

Vergleichen Sie GMED mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GMED Globus Medical Inc	56.57	8.05B	2.51B	185.56M	517.59M	1.34
ABT Abbott Laboratories	132.57	232.02B	43.11B	13.94B	6.78B	7.9963
BSX Boston Scientific Corp	95.41	144.14B	18.49B	2.50B	3.49B	1.6801
SYK Stryker Corp	364.60	141.53B	23.82B	2.92B	4.02B	7.5574
MDT Medtronic Plc	95.45	123.78B	34.20B	4.69B	5.30B	3.6218
EW Edwards Lifesciences Corp	73.94	44.14B	5.69B	1.41B	577.90M	6.9828

Globus Medical Inc Stock (GMED) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-05-27	Herabstufung	BTIG Research	Buy → Neutral
2025-01-10	Hochstufung	BofA Securities	Underperform → Neutral
2024-12-02	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2024-08-07	Hochstufung	Wells Fargo	Equal Weight → Overweight
2024-05-20	Hochstufung	Piper Sandler	Neutral → Overweight
2024-03-18	Hochstufung	BTIG Research	Neutral → Buy
2023-10-20	Eingeleitet	ROTH MKM	Buy
2023-09-19	Hochstufung	Stifel	Hold → Buy
2023-03-30	Hochstufung	Canaccord Genuity	Hold → Buy
2023-02-13	Herabstufung	BofA Securities	Buy → Underperform
2023-02-10	Herabstufung	BTIG Research	Buy → Neutral
2023-02-10	Herabstufung	Loop Capital	Buy → Hold
2023-02-10	Herabstufung	Needham	Buy → Hold
2023-02-10	Herabstufung	Truist	Buy → Hold
2023-02-10	Herabstufung	Wells Fargo	Overweight → Equal Weight
2022-10-18	Eingeleitet	Barclays	Overweight
2022-10-12	Eingeleitet	Jefferies	Buy
2022-04-13	Fortgesetzt	Truist	Buy
2022-03-28	Eingeleitet	Wells Fargo	Overweight
2022-01-04	Hochstufung	Piper Sandler	Neutral → Overweight
2021-12-13	Hochstufung	BofA Securities	Underperform → Buy
2021-12-10	Eingeleitet	RBC Capital Mkts	Outperform
2021-10-29	Eingeleitet	Loop Capital	Buy
2021-02-18	Fortgesetzt	Needham	Buy
2020-12-08	Eingeleitet	Citigroup	Buy
2020-10-20	Eingeleitet	Stifel	Hold
2020-08-06	Bestätigt	Needham	Buy
2020-08-06	Hochstufung	Northland Capital	Market Perform → Outperform
2020-07-21	Eingeleitet	Northland Capital	Market Perform
2020-07-06	Herabstufung	Piper Sandler	Overweight → Neutral
2020-05-08	Bestätigt	Needham	Buy
2020-03-18	Hochstufung	BTIG Research	Neutral → Buy
2020-01-08	Eingeleitet	SunTrust	Buy
2019-12-12	Hochstufung	Wells Fargo	Market Perform → Outperform
2019-08-02	Bestätigt	Needham	Buy
2019-05-24	Herabstufung	Wells Fargo	Outperform → Market Perform
2019-05-03	Bestätigt	Needham	Buy
2019-02-28	Hochstufung	UBS	Neutral → Buy
2019-01-02	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2018-08-02	Bestätigt	Needham	Buy
2018-06-27	Herabstufung	BofA/Merrill	Neutral → Underperform
2018-06-01	Eingeleitet	Cantor Fitzgerald	Overweight
2018-05-03	Bestätigt	Needham	Buy
2018-04-04	Hochstufung	Needham	Hold → Buy

Alle ansehen

Globus Medical Inc Aktie (GMED) Neueste Nachrichten

03:56 AM

What drives Globus Medical Inc GM0N stock priceMarket Insider Reports & Amplify Gains With Picks - earlytimes.in

03:56 AM

Oct 10, 2025

Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know - Yahoo

Oct 10, 2025

Is Globus Medical Inc. (GM0N) stock ideal for retirement investors2025 Valuation Update & Long-Term Growth Stock Strategies - newser.com

Oct 10, 2025

RBC Cuts Price Target on Globus Medical to $88 From $95, Keeps Outperform Rating - MarketScreener

Oct 10, 2025

Will Globus Medical Inc. Class stock rise with strong economy2025 Market WrapUp & AI Based Buy and Sell Signals - newser.com

Oct 10, 2025

Applying Wyckoff theory to Globus Medical Inc. stock2025 Analyst Calls & Free Real-Time Market Sentiment Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

What analysts say about Globus Medical Inc GM0N stockPrice Support Zones & High Profit Market Ideas - earlytimes.in

Oct 09, 2025

A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $82 to $100 - 富途牛牛

Oct 09, 2025

Volatility clustering patterns for Globus Medical Inc.2025 EndofYear Setup & Safe Entry Zone Tips - newser.com

Oct 09, 2025

Globus Medical's (GMED) Hold (C) Rating Reiterated at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 08, 2025

Globus Medical Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo

Oct 08, 2025

Oct 07, 2025

Can Globus Medical’s (GMED) Global Expansion Unlock Sustainable Returns for Investors? - Sahm

Oct 07, 2025

Oct 06, 2025

Winners And Losers Of Q2: Globus Medical (NYSE:GMED) Vs The Rest Of The Medical Devices & SuppliesSpecialty Stocks - FinancialContent

Oct 06, 2025

Has Globus Medical Inc. formed a bullish divergenceJuly 2025 Update & Breakout Confirmation Trade Signals - newser.com

Oct 06, 2025

Top 3 Stocks Generating Strong Free Cash Flow | Stride, Globus Medical, EXLNews and Statistics - IndexBox

Oct 06, 2025

Oct 05, 2025

Comparing Globus Medical Inc. in custom built stock radarsJuly 2025 PostEarnings & AI Based Buy/Sell Signal Reports - newser.com

Oct 05, 2025

Is Globus Medical Inc. Class stock supported by free cash flowProfit Target & Fast Gain Swing Trade Alerts - newser.com

Oct 05, 2025

Oct 04, 2025

Globus Medical (GMED): Evaluating Valuation After New Products, Growth, and ROIC Slowdown - Sahm

Oct 04, 2025